
Organogenesis Holdings Inc.
Organogenesis Holdings Inc. (ORGO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ORGO · as of Jun 8, 2026
Key Statistics
Explore Organogenesis Holdings Inc. Data
orgo stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 5 · Buy rate: 80.0%
The ORGO analyst consensus is Buy, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $3.00, representing +26.05% upside from the current price of $2.38.
Competitors & Peers
orgo competitorsStock Performance
Full HistoryAbout Organogenesis Holdings Inc.
Organogenesis Holdings Inc. is a U.S.-based regenerative medicine firm that specializes in creating, producing, and marketing innovative therapies for advanced wound management, as well as surgical an…
what is organogenesis holdings inc. · orgo stock overview · organogenesis holdings inc. company profile · who is organogenesis holdings inc. ceo · orgo NASDAQ · organogenesis holdings inc. headquarters · organogenesis holdings inc. business segments
About Stock Overview & Key Data
Organogenesis Holdings Inc. (ORGO) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since Jan 5, 2017. As of the latest trading session, ORGO stock price is $2.38, with a market capitalization of $306.2M. The stock has returned -30.81% over the past 12 months and -54.05% year-to-date.
According to 5 Wall Street analysts, the consensus rating for Organogenesis Holdings Inc. stock is Buy, with an average 12-month price target of $3.00. In fiscal year 2025, Organogenesis Holdings Inc. reported revenue of $563.0M and net income of $37.0M. For detailed data — including Organogenesis Holdings Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Organogenesis Holdings Inc. (ORGO) stock price is $2.38. The stock is traded on NASDAQ under the ticker symbol ORGO. The 52-week range is $2.04 – $7.08.